rabeprazole has been researched along with Carcinoma, Intraepithelial in 1 studies
Rabeprazole: A 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niimi, K | 1 |
| Fujishiro, M | 1 |
| Goto, O | 1 |
| Kodashima, S | 1 |
| Minatsuki, C | 1 |
| Hirayama, I | 1 |
| Mochizuki, S | 1 |
| Ono, S | 1 |
| Yamamichi, N | 1 |
| Kakushima, N | 1 |
| Ichinose, M | 1 |
| Koike, K | 1 |
1 other study available for rabeprazole and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Prospective single-arm trial of two-week rabeprazole treatment for ulcer healing after gastric endoscopic submucosal dissection.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Anti-Ulcer Agents; Carcinom | 2012 |